首页>
外国专利>
Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives
Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives
展开▼
机译:可溶性补体受体1(sCR1)及其衍生物的肺部给药
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method is disclosed for treating diseases or disorders involving complement by pulmonary administration of complement inhibitory proteins such as soluble complement receptor type 1 (sCR1). The present invention relates to the direct treatment of certain complement related disorders by administering complement inhibitory proteins via the pulmonary route, in particular, by direct delivery to the lungs by aerosolization of a complement inhibitory protein and subsequent inhalation.
展开▼